Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

171

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Alzheimer's Disease
Interventions
DRUG

AC-3933

5mg twice daily

DRUG

AC-3933

AC-3933, 20 mg twice daily

OTHER

Sugar Pill

Sugar Pill twice daily

Trial Locations (34)

19046

The Clinical Trial Center, Jenkintown

23185

The Center for Excellence in Aging and Geriatric Health, Williamsburg

23229

International Clinical Research Associates LLC, Richmond

32763

Medical Research Group of Central Florida, Orange City

32806

Compass Research LLC, Orlando

33016

Berma Research Group, Hialeah

33064

Memory Disorder Clinic, Deerfield Beach

33135

Advanced Research Institute of Miami, Miami

Research Institute of Miami, Miami

33173

Research Center of Florida Inc., Miami

33613

Department of Psychiatry and Behavioral Medicine, Tampa

Stedman Clinical Trials LLC, Tampa

37232

Precise Research Centers INc., Flowood

38105

UT Medical Group Inc., Memphis

42003

Four Rivers Clinical Research Inc., Paducah

49684

Northern Michigan Neurology, Traverse City

53454

Minneapolis

55416

Clinical Psychopharmacology Consultants PA, Saint Louis Park

58104

Odyssey Researcfh, Fargo

63128

Psych Care Consultants Research, St Louis

72205

Clinical Trials Inc., LIttle Rock

ClinicalStudies Center LLC, Little Rock

73112

Paradigm Research Professionals LLP, Oklahoma City

73116

Cutting Edge Research Group, Oklahoma City

74104

Tulsa Clinical Research LLC, Tulsa

85013

PsyPharma Clinical Research Inc., Phoenix

92103

Pacific Research Network, San Diego

92691

Clinical Trials Associates, Mission Viejo

92868

University of California, Orange

93311

Vertex Clinical Research, Bakersfield

93720

Margolin Brain Institute, Fresno

94705

East Bay Physicians Medical Grou[, Berkeley

98405

Internal Medicine Northwest, Tacoma

05201

Neurological Research Center, Inc., Bennington

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT00359944 - Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease | Biotech Hunter | Biotech Hunter